4

OWNERSHIP DOCUMENT

Company: Petros Pharmaceuticals, Inc.
Filed: January 2, 2026
Period of Report: January 2, 2026
Accession Number: 0001104659-26-000237

View Document ↗ View on SEC.gov ↗